Sinus Node Dysfunction

How to Cite This Chapter: Acosta Velez JG, Amit G, Hernández Ruiz EA, Trusz-Gluza M, Leśniak W. Sinus Node Dysfunction. McMaster Textbook of Internal Medicine. Kraków: Medycyna Praktyczna. https://empendium.com/mcmtextbook/chapter/B31.II.2.7.1 Accessed December 09, 2022.
Last Updated: February 8, 2022
Last Reviewed: February 8, 2022
Chapter Information

Definition, Etiology, PathogenesisTop

Sinus node dysfunction refers to pathologies resulting in inappropriately low heart rates that are insufficient for the current physiologic needs and thus cause clinical symptoms.

Disorders of sinus node automaticity and conduction may be intermittent or persistent; persistent disorders are referred to as sick sinus syndrome (SSS). In patients with bradycardia following episodes of supraventricular tachycardia (most commonly atrial fibrillation [AF] known as postconversion pauses), tachycardia-bradycardia syndrome is diagnosed.

Causes: Ischemic heart disease, systemic connective tissue disease, postoperative complications, idiopathic degeneration related to aging, functional sinus node dysfunction (due to vagal reflexes, disturbances in serum electrolyte levels [hypokalemia or hyperkalemia], metabolic abnormalities [hypothyroidism, hypothermia, anorexia nervosa], neurologic conditions [elevated intracranial pressure, central nervous system tumors], obstructive sleep apnea), drugs (beta-blockers, diltiazem or verapamil, digitalis, class I antiarrhythmic drugs [see Table 3.4-1], amiodarone, lithium).

Sinus node dysfunction is frequently accompanied by loss of a normal chronotropic response to exercise, that is, inability to achieve 85% of the maximum heart rate predicted for age, and in 20% to 30% of patients, by atrioventricular or intraventricular conduction disturbances.

Clinical Features and Natural HistoryTop

Signs and symptoms: see Disorders of Automaticity and Conduction.

Sinus node dysfunction may be transient/intermittent (eg, following myocardial infarction, drug induced) or persistent. Prognosis primarily depends on the underlying condition, concomitant tachyarrhythmias, length of the sinus pauses, and risk of thromboembolic complications (stroke or peripheral embolism) if the patient has concomitant AF (see Atrial Fibrillation).

DiagnosisTop

Diagnostic Criteria

Electrocardiography (ECG):

1) Sinus bradycardia: Sinus rhythm with heart rates <50 beats/min when awake.

2) Sinus pause: No sinus P wave in a period longer than a PP interval of baseline rhythm. The pause is not a multiplication of the normal PP intervals.

3) Sinoatrial (SA) block: We use a similar denomination as the one used for AV blocks. Some of the sinus impulses are “blocked” before they can leave the SA node:

a) Mobitz type I (Wenckebach): A progressive increase in the SA conduction time until one beat is blocked, which is reflected in a progressive shortening of the PP interval, followed by an absent P wave-QRS complex.

b) Mobitz type II: Intermittent P waves “drop out” of the rhythm, while subsequent P waves arrive “on time.” The resulting pause is a multiplication of baseline sinus rhythm.

c) Third-degree SA block: Complete absence of P waves.

4) Tachycardia-bradycardia syndrome: Commonly seen as a prolonged postconversion pause after an episode of AF transitioning to sinus rhythm.

The diagnosis of SSS requires documented symptoms during an episode of bradycardia <40 beats/min or pauses >3 seconds during daytime. Prolonged Holter monitoring is the best diagnostic tool. Atrial flutter and AF may mask sinus node dysfunction, which is revealed only after cardioversion.

Differential Diagnosis

Other causes of syncope (see Syncope).

TreatmentTop

1. Management of symptomatic bradycardia: see Figure 3.2-4.

2. Long-term management:

1) In the case of patients involved in sports, stop training, perform a follow-up assessment, and decide about the possible continuation of training based on the results.

2) Optimize treatment of the underlying condition and discontinue drugs causing bradycardia.

3) Theophylline may be useful in some patients but it is rarely suitable for long-term therapy and not used in Canada.

4) Implantation of a cardiac pacemaker (see Disorders of Automaticity and Conduction) in patients with persistent bradycardia causing unequivocally documented symptoms or with intermittent bradycardia caused by sinus pauses or SA block. The recommended first-line mode of stimulation is DDDR (or DDD in patients with persistent bradycardia and no chronotropic incompetence) with delayed ventricular stimulation.

We would love to hear from you

Comments, mistakes, suggestions?

Partner

Industry Partners

We use cookies to ensure you get the best browsing experience on our website. Refer to our Cookies Information and Privacy Policy for more details.